Loomis, Sayles & Company has played an integral role in Boston Medical Center’s Center for Addiction Treatment for Adolescent/Young Adults who use Substances (CATALYST), which provides integrated primary care and addiction treatment for adolescents and young adults in a non-stigmatizing health care setting. The company was one of CATALYST’s first supporters, providing substantial funding through three gifts since its inception.

The company’s most recent gift of $75,000 has aided in the expansion of the CATALYST model to neighboring community health centers; Loomis’s support specifically focused on expansion to Dothouse Health Center in Dorchester. The extension increases access to addiction treatment and services for adolescents and young adults—one of the state’s most vulnerable patient populations.

The expansion of the CATALYST model has provided crucial, in-depth support for young adult patients at the health center. Young adult patients with a Substance Use Disorder (SUD) are now specifically identified throughout the health center, and the provider can immediately consult a recovery coach specializing in this population to create a tailored care plan to help the patient work toward recovery.

Over the years, Loomis, Sayles & Company has also embedded itself in BMC’s overarching mission of exceptional care, without exception, by donating more than $1,000,000 in support of various initiatives throughout the hospital.

“Loomis Sayles has supported BMC for over 25 years,” says Meg Clough, director of community investments at Loomis, Sayles & Company. “We made that choice because it is the medical center which serves families in the city of Boston who need it most. We fell in love with BMC’s commitment to providing integrated, sustainable care with dignity.”

Loomis, Sayles & Company has been monumental in helping BMC remain a national leader in caring for a compromised patient population, building upon evidence-based services proven to positively change the trajectory of patients’ lives.